“…The CB1 receptors are located in areas of the cerebellum, basal ganglia, hippocampus, cerebral cortex, spinal cord, and peripheral nerves, and are responsible for the psychotropic effects of endocannabinoids. In contrast, CB2 receptors may be reported in cells of the immune system, T cells, B cells, and spleen and may be in part associated with the modulatory effects in pain and inflammatory responses (BONFÁ et al, 2008;BRUCKI et al, 2015;MURNION, 2015;ABRAMS, 2016;MAIDA & DAENINCK, 2016; TURGEMAN & BAR-SELA, 2017) ( Figure 1).…”